pharmaphorum
SEPTEMBER 28, 2020
The FDA has launched its Digital Health Center of Excellence (DHCoE), as the agency continues with its commitment to advancing use of technology such as mobile health devices, software and wearables to create medical products. Housed within the agency’s Center for Devices and Radiological Health, the DHCoE is part of a wider strategy to encourage development of digital health products and therapeutics.
Outsourcing Pharma
SEPTEMBER 28, 2020
Ena Respiratoryâs preventative nasal spray treatment could reach human trials within four months, following results from an animal study released today which showed the spray reduced COVID-19 replication by up to 96%.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
Druggist
SEPTEMBER 30, 2020
Buscopan and mebeverine are two common drugs used for symptomatic treatment of irritable bowel syndrome (IBS). Both drugs can be prescribed by a doctor or purchased over the counter from pharmacies and in case of Bucopa IBS relief from supermarkets. Buscopan vs Mebeverine lists similarities and differences between both drugs. I will review their role in the management of IBS in accordance with the treatment guidelines on irritable bowel syndrome.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
SEPTEMBER 15, 2020
The Royal Society of Chemistry has launched its new Text and Data Mining (TDM) solution, making its full collection of research journals available to companies for AI and machine learning applications. With the volume of published research available growing hourly, access to the RSC’s collection in machine-readable format offers companies the opportunity to extract, pinpoint.
Pharma Tutor
SEPTEMBER 12, 2020
About Author. Nrusingha Panda. Department of Quality Assurance, Mankind Pharma Ltd.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Outsourcing Pharma
SEPTEMBER 30, 2020
The companyâs Phase II trial of ultramicronized PEA has received FDA approval and expects to begin dosing patientparticipants as early as next month.
Pharma Marketing Network
SEPTEMBER 14, 2020
Fast-tracking digital communication is now the new normal across many industries. The healthcare industry is no exception, and for pharma sales reps engaging with healthcare professionals, human connection is key. But today, communication between your reps and HCPs may be limited, or even embargoed altogether. Yet there are still a number of opportunities for engagement, and using video is one that offers various ways to maintain these connections.
Druggist
SEPTEMBER 15, 2020
Cold sores are a common viral infection caused by herpes simplex virus. Cold sores usually affect the area around the mouth (usually caused by the herpes simplex virus 1) or the genital area (usually caused by the herpes simplex virus 2). Cold sore can affect children and adults. Zovirax cream for cold sores can be purchased over the counter from pharmacies and supermarkets.
Pharma Mirror
SEPTEMBER 23, 2020
Pharmacists are healthcare professionals who have enough knowledge about the effective uses of medications. World Pharmacist Day is celebrated on 25th September every year since 2010 on the day FIP (International Pharmaceutical Federation) started their journey. FIP encourages pharmacists to celebrate this day to promote and support the role of the pharmacist in the whole.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Tutor
SEPTEMBER 12, 2020
About Authors. Rajora Priyanka Singh*, Rathore Kamal Singh. Faculty of Pharmacy, BN University, Udaipur-Raj.313001. *singhpriyanka20355@gmail.
pharmaphorum
SEPTEMBER 23, 2020
Sixfold Bioscience and Medicines Discovery Catapult awarded Innovate UK grant to pursue ground-breaking project. Sixfold Bioscience in partnership with Medicines Discovery Catapult, has been given the green light, through the award of an Innovate UK Smart Grant to test a pioneering system designed to deliver drugs directly to cancerous cells, without impacting the healthy cells around it.
Outsourcing Pharma
SEPTEMBER 8, 2020
The company has submitted an investigational new drug application for FSD201, a possible therapy for patients with severe cases of the virus.
Pharma Times
SEPTEMBER 16, 2020
The deadline for entering the 2020 PharmaTimes Communications Awards, Sales Awards and Marketer of the Year competitions has been extended to Friday October 2 after a last-minute spike in enquiries
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Druggist
SEPTEMBER 20, 2020
Baby thrush (oral thrush) is a common condition caused by candida infection (fungal infection) and mostly affecting new-born babies. Thrush can affect breastfeeding mothers (thrush present in the breast) and babies, with thrush affecting the inside of the mouth or causing a nappy rash. This post will focus on the treatment of oral baby thrush. Parents have only one option for baby thrush treatment – over the counter antifungal oral gel (Daktarin Sugar-Free 2% Oral Gel), which be purchased
Pharma Mirror
SEPTEMBER 4, 2020
The first digital session of Medical Device Innovation Summit concludes on a positive note with industry leaders addressing burning topics to promote innovation in the medical equipment industry. From challenges like lack of regulatory systems to its new found potential of manufacturing indigenous products on a large scale, the summit successfully addressed discussions on new.
pharmaphorum
SEPTEMBER 23, 2020
Life science companies must evolve and find new ways of working that erase the lines between industries and sub-sectors if they are to adapt to the digitalised world. That’s according to the team at Sweden’s Sahlgrenska Science Park, who are getting ready to host a virtual event looking at how the specialisation of digital expertise is driving a trend of sector convergence that pharma is only just cottoning on to.
pharmaphorum
SEPTEMBER 24, 2020
A potential COVID-19 breath test has been unveiled in the UK, as the country desperately searches for alternatives to crippling lockdown measures to prevent the disease from spreading. The breath test has been developed by Integumen in collaboration with Modern Water, Avacta and Aptamer Group, which had been working on test that identifies the SARS-CoV-2 coronavirus in waste water.
pharmaphorum
SEPTEMBER 30, 2020
Regeneron’s antibody cocktail seems to reduce levels of coronavirus and improve symptoms in patients, according to early test results. This first data comes from a descriptive analysis from the seamless phase 1/2/3 trial that Regeneron hopes will hurry the medicine dubbed REGN-COV2 to market. The ongoing double-blind trial measures the effect of adding REGN-COV2 to usual standard of care, compared with usual standard of care.
pharmaphorum
SEPTEMBER 21, 2020
Compass Pathways and its potential magic mushroom depression drug went public last week – and now psychedelic therapy firm Mind Medicine is aiming to follow suit by up-listing its shares on the Nasdaq. UK-based Compass has a patented synthetic version of psilocybin, the active ingredient in magic mushrooms, and raised around $127.5 million with its IPO on Friday and shares are still significantly above their launch price of $17.
pharmaphorum
SEPTEMBER 10, 2020
Two UK biotechs – Destiny Pharma and Sporegen – have joined forces to develop a nasal spray that they say could serve as a first line of defense against coronavirus infections. The nasal spray could provide protection from infection within a few days of administration, and would be easy to make in bulk at a low cost, say the partners. The programme is still in the early stages of development, but if it works in trials would provide another approach to prevent transmission of SARS-CoV-2, the viru
pharmaphorum
SEPTEMBER 21, 2020
Amazon’s Alexa device can already field health and medical questions, but the library of responses has now been bulked up thanks to a partnership with digital health company Sharecare. The new deal adds more than 80,000 questions and answers to the repertoire of the Alexa virtual assistant, which provides information, entertainment and advice to users on voice command via devices such as Amazon’s Echo smart speakers.
pharmaphorum
SEPTEMBER 29, 2020
The pharmaceutical industry is one of the most scientifically innovative and competitive industries, particularly in oncology. As of 2018, there were over 1,100 cancer therapies in development, and as of 2020, 362 of them were cell and gene therapies. As a result, there is a need for continued innovation and increased efficiency in terms of drug development to manage cost, complexity and speed to provide potentially transformative therapies for cancer patients.
pharmaphorum
SEPTEMBER 17, 2020
Eli Lilly has followed up supportive data from its Olumiant in COVID-19 with results of a study showing its antibody treatment could help prevent hospitalisation from the disease. An interim analysis of the BLAZE-1 clinical trial showed a reduced rate of hospitalisation in patients treated with Lilly’s LY-CoV555, an antibody that neutralises the SARS-CoV-2 coronavirus, in a phase 2 trial.
pharmaphorum
SEPTEMBER 2, 2020
While the effects of COVID-19 have been devastating for many industries, its positive impact on accelerating the uptake of digital health technologies and virtual collaboration solutions is undeniable. This has been a long time coming and there are countless reasons why I believe virtual collaboration and medical education are here to stay, long after there is a vaccine for COVID-19 and physical distancing guidelines have been lifted. 1.
pharmaphorum
SEPTEMBER 24, 2020
An artificial intelligence-powered diagnostic for autism spectrum disorder (ASD), developed by Cognoa, has met all its objectives in a pivotal trial and will be filed for approval with the FDA. The ASD diagnostic app is designed to serve as a tool that can be used by paediatricians in primary care to detect autism traits early on and start treatment sooner.
pharmaphorum
SEPTEMBER 2, 2020
The UK’s medicines regulator has published long-awaited guidance on regulation of medicines and medical devices as the UK approaches the end of its Brexit transition period at the end of the year. This would see the UK mirroring decisions made by the European Medicines Agency, while also laying out a process should companies wish to file for a separate approval in the UK.
pharmaphorum
SEPTEMBER 28, 2020
Shares in UK biotech Valirx were up sharpy this morning after its lead drug VAL201 showed evidence of efficacy in advanced prostate cancer in its first clinical trial. The company reported results from 11 patents taking part in the phase 1/2 study which showed a 54.5% overall response rate with VAL201, with a promising safety and tolerability profile.
pharmaphorum
SEPTEMBER 2, 2020
Digital health firm Mobio Interactive has closed a $1.8 million seed fund to advance development of its meditation app Am Mindfulness. Mobio said that the app, known as Am for short, is the first and only meditation app to outperform placebo in randomised controlled trials. MI’s Seed raise was led by the Singapore-based Verge HealthTech Fund along with Atlas Asset Management , Creative Ventures and VC giant SOSV.
pharmaphorum
SEPTEMBER 15, 2020
As pharmaceutical marketers prepare their brands for the future, there are a number of important ways they can learn from digitally-native brands. Companies like prescription glasses firm Warby Parker, shoe brand Rothy’s and tele-dentistry’s SmileDirectClub have grown up in today’s digitally native environment and can offer some key pointers for pharma.
pharmaphorum
SEPTEMBER 11, 2020
Brent Saunders has been out of the limelight for a few months since departing Allergan after its takeover by AbbVie, but now he is back in a leading role at Vesper Healthcare Acquisition, set up to acquire assets in the healthcare sector. Delaware-incorporated Vesper has filed a with a $400 million initial public offering (IPO) and plans to list on the Nasdaq under the symbol VSRU, with Goldman Sachs and JP Morgan acting as bookrunners.
pharmaphorum
SEPTEMBER 8, 2020
An EU consumer body has urged the European Commission to keep compensation measures in place for people who might be harmed in COVID-19 vaccine trials, responding to reports that the drug industry is lobbying to reduce liability. In a letter to the Commissioner for Health and Food Safety Stella Kyriakides, the BEUC says that even though the need for a coronavirus vaccine is urgent, access “must go hand in hand with adequate consumer compensation in case of harm.”.
pharmaphorum
SEPTEMBER 29, 2020
UK Prime Minister Boris Johnson has told the UN General Assembly that the UK will donate £571 million ($735 million) to the COVAX scheme aimed at distributing COVID-19 vaccines fairly around the world. The lion’s share of that total – around £500 million – will be “for developing countries to protect themselves,” said the PM in a recorded speech given to the assembly, delivered just before the number of deaths due to coronavirus topped 1 million worldwide.
pharmaphorum
SEPTEMBER 18, 2020
AstraZeneca is a company with a turbulent history but, for now, a promising future. We take a look at the company’s story, from its creation as a merger of two equals, to its recent major restructuring and its drives in cutting-edge oncology and COVID-19. In 1998, Europe’s corporate landscape was riding a “merger wave” – intensive competitive pressure meant that opportunities arose for companies to merge with their competitors in order to rationalise both businesses.
Expert insights. Personalized for you.
143 
Let's personalize your content